KR102680172B1 - Donut containing ingredient that help with weight control - Google Patents
Donut containing ingredient that help with weight control Download PDFInfo
- Publication number
- KR102680172B1 KR102680172B1 KR1020230035697A KR20230035697A KR102680172B1 KR 102680172 B1 KR102680172 B1 KR 102680172B1 KR 1020230035697 A KR1020230035697 A KR 1020230035697A KR 20230035697 A KR20230035697 A KR 20230035697A KR 102680172 B1 KR102680172 B1 KR 102680172B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- powder
- donut
- donuts
- milk
- Prior art date
Links
- 235000012489 doughnuts Nutrition 0.000 title claims abstract description 48
- 239000004615 ingredient Substances 0.000 title claims description 25
- 238000004260 weight control Methods 0.000 title abstract description 23
- 238000004519 manufacturing process Methods 0.000 claims abstract description 15
- 239000000843 powder Substances 0.000 claims description 73
- 235000009499 Vanilla fragrans Nutrition 0.000 claims description 16
- 235000012036 Vanilla tahitensis Nutrition 0.000 claims description 16
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 14
- ZMJBYMUCKBYSCP-UHFFFAOYSA-N Hydroxycitric acid Chemical compound OC(=O)C(O)C(O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-UHFFFAOYSA-N 0.000 claims description 13
- 241000533293 Sesbania emerus Species 0.000 claims description 13
- 235000018102 proteins Nutrition 0.000 claims description 13
- 102000004169 proteins and genes Human genes 0.000 claims description 13
- 108090000623 proteins and genes Proteins 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 12
- 239000003765 sweetening agent Substances 0.000 claims description 12
- 108010046377 Whey Proteins Proteins 0.000 claims description 11
- 102000007544 Whey Proteins Human genes 0.000 claims description 11
- 235000013325 dietary fiber Nutrition 0.000 claims description 11
- 235000021119 whey protein Nutrition 0.000 claims description 11
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 10
- 235000014571 nuts Nutrition 0.000 claims description 10
- 244000144725 Amygdalus communis Species 0.000 claims description 9
- 235000020224 almond Nutrition 0.000 claims description 9
- 229940069765 bean extract Drugs 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 238000004091 panning Methods 0.000 claims description 9
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 8
- 235000017003 Cissus Nutrition 0.000 claims description 8
- 235000017014 Cissus repens Nutrition 0.000 claims description 8
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 229960003080 taurine Drugs 0.000 claims description 7
- 229920001285 xanthan gum Polymers 0.000 claims description 7
- 239000000230 xanthan gum Substances 0.000 claims description 7
- 235000010493 xanthan gum Nutrition 0.000 claims description 7
- 229940082509 xanthan gum Drugs 0.000 claims description 7
- 239000000679 carrageenan Substances 0.000 claims description 6
- 229920001525 carrageenan Polymers 0.000 claims description 6
- 235000010418 carrageenan Nutrition 0.000 claims description 6
- 229940113118 carrageenan Drugs 0.000 claims description 6
- 235000020197 coconut milk Nutrition 0.000 claims description 6
- 235000003599 food sweetener Nutrition 0.000 claims description 6
- 235000013336 milk Nutrition 0.000 claims description 6
- 239000008267 milk Substances 0.000 claims description 6
- 210000004080 milk Anatomy 0.000 claims description 6
- 235000021092 sugar substitutes Nutrition 0.000 claims description 6
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 6
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 claims description 5
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims description 5
- 241000208140 Acer Species 0.000 claims description 5
- 102000002322 Egg Proteins Human genes 0.000 claims description 5
- 108010000912 Egg Proteins Proteins 0.000 claims description 5
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 5
- 235000019864 coconut oil Nutrition 0.000 claims description 5
- 239000003240 coconut oil Substances 0.000 claims description 5
- 235000014103 egg white Nutrition 0.000 claims description 5
- 210000000969 egg white Anatomy 0.000 claims description 5
- 235000013601 eggs Nutrition 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 239000008347 soybean phospholipid Substances 0.000 claims description 5
- 235000020357 syrup Nutrition 0.000 claims description 5
- 239000006188 syrup Substances 0.000 claims description 5
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 4
- 229920001661 Chitosan Polymers 0.000 claims description 3
- 244000290333 Vanilla fragrans Species 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 2
- 244000035145 Cissus repens Species 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 13
- 239000000463 material Substances 0.000 abstract description 6
- 235000015872 dietary supplement Nutrition 0.000 abstract description 3
- 244000263375 Vanilla tahitensis Species 0.000 description 13
- 230000000694 effects Effects 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 241001355260 Cissus Species 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 230000000968 intestinal effect Effects 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 4
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 4
- 210000000577 adipose tissue Anatomy 0.000 description 4
- 229940074393 chlorogenic acid Drugs 0.000 description 4
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 4
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 4
- 235000001368 chlorogenic acid Nutrition 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 241000593508 Garcinia Species 0.000 description 3
- 235000000885 Garcinia xanthochymus Nutrition 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 3
- 229940107187 fructooligosaccharide Drugs 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 208000016261 weight loss Diseases 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 240000007049 Juglans regia Species 0.000 description 2
- 235000009496 Juglans regia Nutrition 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 240000006711 Pistacia vera Species 0.000 description 2
- 235000003447 Pistacia vera Nutrition 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 235000014510 cooky Nutrition 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 102000038379 digestive enzymes Human genes 0.000 description 2
- 108091007734 digestive enzymes Proteins 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000005802 health problem Effects 0.000 description 2
- 229940089491 hydroxycitric acid Drugs 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- -1 lipid peroxides Chemical class 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 235000020233 pistachio Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000018648 unbalanced nutrition Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000020234 walnut Nutrition 0.000 description 2
- UBLAMKHIFZBBSS-UHFFFAOYSA-N 3-Methylbutyl pentanoate Chemical compound CCCCC(=O)OCCC(C)C UBLAMKHIFZBBSS-UHFFFAOYSA-N 0.000 description 1
- 102000004146 ATP citrate synthases Human genes 0.000 description 1
- 108090000662 ATP citrate synthases Proteins 0.000 description 1
- 244000226021 Anacardium occidentale Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000206576 Chondrus Species 0.000 description 1
- 241000206575 Chondrus crispus Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 235000017925 Cissus antarctica Nutrition 0.000 description 1
- 241001355250 Cissus antarctica Species 0.000 description 1
- 240000000542 Cissus nodosa Species 0.000 description 1
- 235000018211 Cissus rhombifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241000546193 Clusiaceae Species 0.000 description 1
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical class OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical class OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Chemical class O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- 241000134253 Lanka Species 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 241000289581 Macropus sp. Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241000745768 Pluchea carolinensis Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 241000589636 Xanthomonas campestris Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000020226 cashew nut Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 235000001916 dieting Nutrition 0.000 description 1
- 230000037228 dieting effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000004129 fatty acid metabolism Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 235000008316 grape ivy Nutrition 0.000 description 1
- 230000037219 healthy weight Effects 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
- 230000007056 liver toxicity Effects 0.000 description 1
- 208000020442 loss of weight Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000007968 orange flavor Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000001076 sarcopenia Diseases 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000021413 well-balanced diet Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/40—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
-
- A—HUMAN NECESSITIES
- A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
- A47J—KITCHEN EQUIPMENT; COFFEE MILLS; SPICE MILLS; APPARATUS FOR MAKING BEVERAGES
- A47J37/00—Baking; Roasting; Grilling; Frying
- A47J37/12—Deep fat fryers, e.g. for frying fish or chips
- A47J37/1214—Deep fat fryers, e.g. for frying fish or chips the food being transported through an oil-bath
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/24—Heat, thermal treatment
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/34—Membrane process
Abstract
본 발명은 체중 조절용 식품 또는 식품 보조제에 관한 것으로, 보다 상세하게는, 체중 조절에 도움이 되는 소재를 포함하여 제조된 도넛 및 그 제조방법에 관한 것이다.The present invention relates to food or food supplements for weight control, and more specifically, to donuts manufactured including materials helpful in weight control and a method of manufacturing the same.
Description
본 발명은 체중 조절용 식품 또는 식품 보조제에 관한 것으로, 보다 상세하게는, 체중 조절에 도움이 되는 소재를 포함하여 제조된 도넛 및 그 제조방법에 관한 것이다.The present invention relates to food or food supplements for weight control, and more specifically, to donuts manufactured including materials helpful in weight control and a method of manufacturing the same.
최근 급속한 경제성장으로 인해 식생활 문화가 빠르게 발달하면서, 양질의 다양한 음식을 쉽게 접할 수 있게 되었는데, 그에 따라 과도한 음식물 섭취로 인해 비만환자가 점차로 늘어나, 이제는 비만이 외관 상의 문제뿐만 아니라 건강 상의 문제로도 사회적 이슈가 되고 있다. Recently, due to rapid economic growth, dietary culture has developed rapidly, and various high-quality foods have become easily accessible. As a result, the number of obese patients is gradually increasing due to excessive food intake, and obesity is now not only a cosmetic problem, but also a health problem. It is becoming a social issue.
사람의 신체가 배가 부른데도 뭔가 더 먹고 싶어하는 이유는 균형잡히지 않은 영양 때문이다. 몸에 꼭 필요한 영양분이 소량이라도 부족하면, 그 부족분을 충족시키기 위해 칼로리는 이미 충분함에도 더 이상 필요없는 다른 영양분과 많은 칼로리를 포함한 다량의 음식물을 먹게 된다. 또한, 심신이 건강한 사람은 먹는 양이나 영양의 구성을 스스로 조절할 수 있고, 이상적인 밸런스를 유지하는 것이 쉽지만, 심신이 건강한 상태가 깨어졌을 때, 심리적 문제가 있거나 스트레스가 심하거나 건강에 이상이 생기면 이 조절능력이 저하된다.The reason a person's body wants to eat more even when they are full is because of unbalanced nutrition. If you are lacking even a small amount of nutrients that your body needs, you will eat a large amount of food containing many calories and other nutrients that are no longer needed to make up for the deficiency, even though you already have enough calories. In addition, people with a healthy mind and body can control the amount of food and the composition of nutrition on their own, and it is easy to maintain an ideal balance, but when the healthy state of mind and body is broken, if there is a psychological problem, if stress is severe, or if there is a health problem, this can happen. Control ability decreases.
또한, 지나치게 정제된 음식, 화학적 식품첨가물로 오염된 음식, 인스턴트 식품 등의 지속적인 섭취와 지속적인 스트레스로 인해 심신에 피로가 누적되어 체중조절 능력을 잃어, 이와 같은 심리적으로나 육체적으로 건강하지 않은 상태가 체중이상을 불러온다. In addition, continuous consumption of overly refined foods, foods contaminated with chemical food additives, instant foods, etc. and constant stress accumulates in the mind and body, causing fatigue and loss of weight control. This psychologically and physically unhealthy state leads to weight loss. It brings about more than just that.
따라서, 체중조절에 있어서 중요한 점은 건강을 되찾을 수 있는 균형잡힌 영양섭취와 효율적으로 자기 몸의 조절체계를 활성화할 수 있는 식이요법 및 적절한 운동, 그리고 체중조절 시 문제가 되는 변비를 해결할 수 있는 식이섬유의 섭취 등이다. Therefore, the important points in weight control are balanced nutritional intake to restore health, diet and appropriate exercise to effectively activate the body's regulatory system, and treatment to resolve constipation, which is a problem during weight control. Intake of dietary fiber, etc.
그러나, 각종 영양소가 균형있게 구성된 식사의 섭취가 바쁜 현대인에게는 현실적으로 어려운 측면이 있다. 그로 인해 식욕을 억제하기 어렵고, 지나친 저열량과 불균형한 영양으로 건강을 해치기 쉬우며, 적게 먹고 운동을 하더라도 의도한 대로 체중이 감량되지 않고, 의도한 체중에 도달하더라도 지속적인 체중유지가 어려워 요요현상이 나타나며, 일회성의 체중감량에 그치기 쉬운 등의 문제들이 반복적으로 나타나 건강한 체중조절을 하는 것은 매우 어려운 현실이다.However, it is realistically difficult for busy modern people to consume a well-balanced diet containing various nutrients. As a result, it is difficult to suppress the appetite, it is easy to harm one's health due to excessive low calories and unbalanced nutrition, and even if one eats less and exercises, one does not lose weight as intended, and even if the intended weight is reached, it is difficult to maintain the weight continuously, resulting in the yo-yo phenomenon. , it is very difficult to maintain healthy weight control as problems such as one-time weight loss appear repeatedly.
본 발명은 상기와 같은 문제점을 해결하기 위한 것으로서, 체중 조절에 도움이 되는 소재를 포함하여 제조된 도넛 및 그 제조방법을 제공하고자 한다.The present invention is intended to solve the above problems and provides a donut manufactured including a material that helps control body weight and a method for manufacturing the same.
본 발명의 상기 및 다른 목적과 이점은 바람직한 실시예를 설명한 하기의 설명으로부터 분명해질 것이다.The above and other objects and advantages of the present invention will become apparent from the following description of preferred embodiments.
상기 목적은, 도넛 총 중량에 대하여, 가르시니아 캄보지아 추출분말 2 내지 3.5 중량%, 그린커피빈 추출분말 0.1 내지 1 중량%, 견과류 분말 28 내지 35 중량%, 코코넛 밀크 5 내지 8 중량%, 우유 8 내지 13 중량%, 계란 5 내지 8 중량% 및 코코넛 오일 10 내지 14 중량% 을 포함하여 제조된 체중 조절용 도넛에 의해 달성될 수 있다. For the above purpose, based on the total weight of the donut, 2 to 3.5% by weight of garcinia cambogia extract powder, 0.1 to 1% by weight of green coffee bean extract powder, 28 to 35% by weight of nut powder, 5 to 8% by weight of coconut milk, and 8 to 8% by weight of milk. 13% by weight, 5 to 8% by weight eggs and 10 to 14% by weight coconut oil.
상기 도넛은, L-카르니틴 0.1 내지 1 중량%, 아몬드 프로틴 파우더 2 내지 5 중량%, 유청 단백질 3 내지 7 중량%, 카라기난 0.1 내지 1 중량%, 타우린 0.1 내지 1 중량%, 잔탄검 0.1 내지 0.5 중량%, 시서스 분말 0.1 내지 1 중량%, 키토 올리고당 0.4 내지 1 중량%, 식이섬유 0.1 내지 1 중량%, 난백분 1 내지 1.5 중량%, 대두레시틴 0.1 내지 0.6 중량%, 베이킹 파우더 1 내지 3 중량%, 탄산칼슘 0.1 내지 2 중량%, 정제염 0.1 내지 1 중량%, 설탕 대체 감미료 3 내지 6 중량%, 프락토올리고당 1 내지 2 중량%, 메이플 시럽 1 내지 2 중량%, 바닐라 페이스트 0.1 내지 1 중량% 및 식용 향료 0.01 내지 2 중량%을 더 포함하는 것을 특징으로 한다. The donut contains 0.1 to 1% by weight of L-carnitine, 2 to 5% by weight of almond protein powder, 3 to 7% by weight of whey protein, 0.1 to 1% by weight of carrageenan, 0.1 to 1% by weight of taurine, and 0.1 to 0.5% by weight of xanthan gum. %, cissus powder 0.1 to 1% by weight, chitooligosaccharide 0.4 to 1% by weight, dietary fiber 0.1 to 1% by weight, egg white powder 1 to 1.5% by weight, soy lecithin 0.1 to 0.6% by weight, baking powder 1 to 3% by weight, Calcium carbonate 0.1 to 2% by weight, refined salt 0.1 to 1% by weight, sugar substitute sweetener 3 to 6% by weight, fructooligosaccharide 1 to 2% by weight, maple syrup 1 to 2% by weight, vanilla paste 0.1 to 1% by weight, and edible It is characterized in that it further contains 0.01 to 2% by weight of fragrance.
상기 목적은, 가르시니아 캄보지아 추출분말, 그린커피빈 추출물 분말 및 견과류 분말을 포함하는 분말 성분을 혼합하여 체에 2회 걸러주어 100 mesh 이상의 크기를 갖는 분말 혼합물을 제조하는 단계; 상기 분말 혼합물에 코코넛 밀크, 우유, 계란 및 코코넛 오일을 포함하는 액상 성분을 혼합하여 반죽물을 형성하는 단계; 상기 반죽물을 짤주머니를 사용하여 도넛 제조용 팬에 도포하고, 팬닝(panning)하는 단계; 및 팬닝 후에 컨백션 오븐에서 164 내지 166℃ 에서, 14 내지 16분간 구워서 도넛을 제조하는 단계; 를 포함하는, 체중 조절용 도넛 제조방법에 의해 달성될 수 있다.The purpose is to prepare a powder mixture having a size of 100 mesh or more by mixing powder ingredients including garcinia cambogia extract powder, green coffee bean extract powder, and nut powder and filtering them twice through a sieve; Forming a dough by mixing liquid ingredients including coconut milk, milk, eggs, and coconut oil with the powder mixture; Applying the dough to a pan for making donuts using a piping bag and panning; and manufacturing donuts by baking them in a convection oven at 164 to 166°C for 14 to 16 minutes after panning; It can be achieved by a method of manufacturing donuts for weight control, which includes.
본 발명에 따르면, 혈당 조절, 체지방 감소의 효능을 갖는 천연 재료 유래의 식물성 성분으로 구성된, 체중 조절에 도움이 될 수 있는 소재를 포함하는 도넛을 제공할 수 있다. 상기 도넛은, 예컨대, 체중 조절용 식품 또는 식품 보조제 등의 형태로 제공될 수 있다. According to the present invention, it is possible to provide a donut containing a material that can help control body weight and is composed of vegetable ingredients derived from natural ingredients that have the effect of controlling blood sugar levels and reducing body fat. The donuts may be provided in the form of, for example, a food for weight control or a food supplement.
또한, 본 발명에 따르면, 비타민, 무기질 등의 생리활성 성분과 건강 기능성이 우수한 견과류 분말을 포함하여 제조함으로써, 보다 건강한 방법으로 체중 조절을 하고자 하는 사람들에게 유용한 대안이 될 수 있다. In addition, according to the present invention, it can be a useful alternative for people who want to control their weight in a healthier way by manufacturing it by including nut powder with excellent health functionality and physiologically active ingredients such as vitamins and minerals.
다만, 본 발명의 효과들은 이상에서 언급한 효과로 제한되지 않으며, 언급되지 않은 또 다른 효과들은 아래의 기재로부터 당업자에게 명확하게 이해될 수 있을 것이다.However, the effects of the present invention are not limited to the effects mentioned above, and other effects not mentioned will be clearly understood by those skilled in the art from the description below.
도 1 내지 도 4는, 본 발명의 일 실시예에 따른 체중 조절용 도넛을 제조하는 단계를 수행하는 실제 사진이다.
도 5는, 본 발명의 일 실시예에 따라 제조된 체중 조절용 도넛의 사진이다.1 to 4 are actual photos of the steps of manufacturing a donut for weight control according to an embodiment of the present invention.
Figure 5 is a photograph of a donut for weight control manufactured according to an embodiment of the present invention.
이하, 본 발명의 실시예와 도면을 참조하여 본 발명을 상세히 설명한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위해 예시적으로 제시한 것일 뿐, 본 발명의 범위가 이들 실시예에 의해 제한되지 않는다는 것은 당업계에서 통상의 지식을 가지는 자에 있어서 자명할 것이다.Hereinafter, the present invention will be described in detail with reference to embodiments of the present invention and drawings. These examples are merely presented as examples to explain the present invention in more detail, and it will be apparent to those skilled in the art that the scope of the present invention is not limited by these examples. .
또한, 달리 정의하지 않는 한, 본 명세서에서 사용되는 모든 기술적 및 과학적 용어는 본 발명이 속하는 기술 분야의 숙련자에 의해 통상적으로 이해되는 바와 동일한 의미를 가지며, 상충되는 경우에는, 정의를 포함하는 본 명세서의 기재가 우선할 것이다.Additionally, unless otherwise defined, all technical and scientific terms used in this specification have the same meaning as commonly understood by a person skilled in the art to which the present invention pertains, and in case of conflict, this specification including definitions The description will take precedence.
도면에서 제안된 발명을 명확하게 설명하기 위해서 설명과 관계없는 부분은 생략하였으며, 명세서 전체를 통하여 유사한 부분에 대해서는 유사한 도면 부호를 붙였다. 그리고, 어떤 부분이 어떤 구성 요소를 "포함"한다고 할 때, 이는 특별히 반대되는 기재가 없는 한 다른 구성 요소를 제외하는 것이 아니라 다른 구성 요소를 더 포함할 수 있는 것을 의미한다. 또한, 명세서에서 기술한 "부"란, 특정 기능을 수행하는 하나의 단위 또는 블록을 의미한다.In order to clearly explain the proposed invention in the drawings, parts unrelated to the description have been omitted, and similar reference numerals have been assigned to similar parts throughout the specification. And, when it is said that a part "includes" a certain component, this means that it does not exclude other components, but may further include other components, unless specifically stated to the contrary. Additionally, “unit” as used in the specification refers to a unit or block that performs a specific function.
각 단계들에 있어 식별부호(제1, 제2, 등)는 설명의 편의를 위하여 사용되는 것으로 식별부호는 각 단계들의 순서를 설명하는 것이 아니며, 각 단계들은 문맥상 명백하게 특정 순서를 기재하지 않는 이상 명기된 순서와 다르게 실시될 수 있다. 즉, 각 단계들은 명기된 순서와 동일하게 실시될 수도 있고 실질적으로 동시에 실시될 수도 있으며 반대의 순서대로 실시될 수도 있다.Identification codes (first, second, etc.) for each step are used for convenience of explanation. The identification codes do not describe the order of each step, and each step does not clearly state a specific order in context. It may be carried out differently from the order specified above. That is, each step may be performed in the same order as specified, may be performed substantially simultaneously, or may be performed in the opposite order.
이하, 첨부된 도면을 참조하여 본원의 구현예 및 실시예를 상세히 설명한다. 그러나, 본원의 이러한 구현예 및 실시예와 도면에 제한되지 않을 수 있다.Hereinafter, implementation examples and examples of the present application will be described in detail with reference to the attached drawings. However, the present disclosure may not be limited to these implementations, examples, and drawings.
본원의 일 측면은, 도넛 총 중량에 대하여, 가르시니아 캄보지아 추출분말 2 내지 3.5 중량%, 그린커피빈 추출분말 0.1 내지 1 중량%, 견과류 분말 28 내지 35 중량%, 코코넛 밀크 5 내지 8 중량%, 우유 8 내지 13 중량%, 계란 5 내지 8 중량% 및 코코넛 오일 10 내지 14 중량% 을 포함하여 제조된 체중 조절용 도넛을 제공한다.One aspect of the present application is, based on the total weight of the donut, 2 to 3.5% by weight of garcinia cambogia extract powder, 0.1 to 1% by weight of green coffee bean extract powder, 28 to 35% by weight of nut powder, 5 to 8% by weight of coconut milk, and milk. Provided is a donut for weight control prepared containing 8 to 13% by weight, 5 to 8% by weight of egg, and 10 to 14% by weight of coconut oil.
본 발명의 체중 조절용 도넛은, 가르시니아 캄보지아 추출분말, 그린커피빈 추출분말 및 견과류 분말 등을 포함함으로써, 보다 건강한 방법으로 체중 조절이 가능할 수 있도록 하면서도, 달콤함과 부드러운 식감 등의 관능성은 높게 유지할 수 있다. The weight control donut of the present invention contains garcinia cambogia extract powder, green coffee bean extract powder, and nut powder, thereby enabling weight control in a healthier way, while maintaining high sensory properties such as sweetness and soft texture. .
가르시니아 캄보지아(Garcinia cambogia)는 인도, 스리랑카 등 동남아시아와 중서부 아프리카에서 자생하는 물레나무과(Guttiferae) 열매 과일이다.Garcinia cambogia is a fruit from the Guttiferae family that grows naturally in Southeast Asia, including India and Sri Lanka, and central and western Africa.
가르시니아 캄보지아에 다량 함유된 하이드록시시트린산(HCA)는 탄수화물이 지방으로 전환될 때 사용되는 효소(ATP-citrate lyase)의 활성을 억제하여 체중과 체지방량을 감소시키는 작용을 한다. Hydroxycitric acid (HCA), contained in large quantities in Garcinia cambogia, works to reduce body weight and body fat by inhibiting the activity of the enzyme (ATP-citrate lyase) used when carbohydrates are converted to fat.
상기 가르시니아 캄보지아는, 통상의 방법에 따라 추출물 형태로 제조될 수 있으며, 인체에 특별한 부작용 없이 체중조절용 기능성 성분으로써 사용될 수 있다. The Garcinia cambogia can be prepared in the form of an extract according to a conventional method, and can be used as a functional ingredient for weight control without any special side effects on the human body.
바람직하게는, 상기 가르시니아 캄보지아 추출물을 통상의 감압 농축을 수행한 후 분말화하여 제조된, 가르시니아 캄보지아 추출분말로 사용될 수 있으며, 상기 도넛 총 중량에 대하여, 2 내지 3.5 중량%, 일례로, 2.7 중량%의 함량으로 포함될 수 있다. Preferably, the Garcinia cambogia extract can be used as a Garcinia cambogia extract powder, which is prepared by concentrating the Garcinia cambogia extract under normal reduced pressure and then pulverizing it, and is used in an amount of 2 to 3.5% by weight, for example, 2.7 weight%, based on the total weight of the donut. It may be included in % content.
상기 가르시니아 캄보지아 추출 분말을 3.5 중량%를 초과하여 포함하면, 간 독성 문제가 야기될 우려가 있고, 2 중량% 미만으로 포함되면, 체중 조절 효과가 미미할 수 있다. If the Garcinia cambogia extract powder is included in more than 3.5% by weight, there is a risk of liver toxicity, and if it is included in less than 2% by weight, the weight control effect may be minimal.
그린커피빈(Green coffee bean)은 로스팅을 하지 않은 커피 생두를 의미하며, 클로로겐산(chlorogenic acid, CGA) 등의 다양한 생리활성 물질을 다량 함유하고 있다.Green coffee beans refer to green coffee beans that have not been roasted, and contain a large amount of various bioactive substances such as chlorogenic acid (CGA).
클로로겐산은 식후 혈중 포도당의 방출을 느리게 하고, 생체 내에서 과산화지질의 생성 억제 효과, 콜레스테롤 생합성 억제효과를 발휘하여 체중 조절에 도움이 된다. 클로로겐산은 글리코겐 및 글루코스-6-인산의 간 내부 농축을 증가시키고 혈당수치를 감소시키는 작용을 하고, 무기질의 분배를 개선시키고, 혈장 및 간의 지방을 감소시키며, 글루코스 내성을 개선시키는 효능을 발휘한다.Chlorogenic acid helps control body weight by slowing the release of glucose into the blood after a meal and by suppressing the production of lipid peroxides and cholesterol biosynthesis in vivo. Chlorogenic acid increases the concentration of glycogen and glucose-6-phosphate in the liver and reduces blood sugar levels, improves mineral distribution, reduces plasma and liver fat, and improves glucose tolerance.
상기 그린커피빈(Green coffee bean)은 통상의 방법에 따라 그린커피빈 주정추출물 형태로 제조될 수 있으며, 체지방 감소 및 체중 조절용 기능성 성분으로써 포함될 수 있다. The green coffee bean can be prepared in the form of green coffee bean alcohol extract according to a conventional method, and can be included as a functional ingredient for reducing body fat and controlling body weight.
바람직하게는, 상기 그린커피빈(Green coffee bean) 추출물은 통상의 감압 농축을 수행한 후 분말화하여 제조된, 그린커피빈 추출분말로 사용될 수 있으며, 상기 도넛 총 중량에 대하여, 0.1 내지 1 중량%, 일례로, 0.67 중량%의 함량으로 포함될 수 있다. Preferably, the green coffee bean extract can be used as a green coffee bean extract powder prepared by performing general reduced pressure concentration and then powdering, and is used in an amount of 0.1 to 1 weight based on the total weight of the donut. %, for example, it may be included in an amount of 0.67% by weight.
상기 견과류 분말은, 예를 들어, 아몬드 분말, 캐슈넛 분말, 피스타치오 분말, 땅콩 분말, 피스타치오 분말 및 호두 분말 중에서 선택되는 1종 이상일 수 있다.The nut powder may be, for example, one or more types selected from almond powder, cashew nut powder, pistachio powder, peanut powder, pistachio powder, and walnut powder.
본 발명의 체중 조절용 도넛은, 열량은 낮으면서, 비타민, 무기질 등이 풍부하고, 유익한 장내균 증가, 뼈 강화, 혈당 조절, 노화방지, 항산화 작용 등의 우수한 건강 기능성을 발휘할 수 있는 견과류 분말을 사용할 수 있다. The weight control donut of the present invention can use nut powder that is low in calories, rich in vitamins, minerals, etc., and can exhibit excellent health functions such as increasing beneficial intestinal bacteria, strengthening bones, controlling blood sugar, anti-aging, and antioxidant activity. there is.
상기 도넛은, L-카르니틴, 아몬드 프로틴 파우더, 유청 단백질, 카라기난 타우린, 잔탄검, 시서스 분말, 키토 올리고당, 식이섬유, 난백분, 대두레시틴, 베이킹 파우더, 탄산칼슘, 정제염, 설탕 대체 감미료, 프락토올리고당, 메이플 시럽, 바닐라 페이스트 및 식용 향료를 포함하는 추가 성분을 더 포함할 수 있다. The donuts include L-carnitine, almond protein powder, whey protein, carrageenan taurine, xanthan gum, cissus powder, keto oligosaccharides, dietary fiber, egg white powder, soy lecithin, baking powder, calcium carbonate, refined salt, sugar substitute sweetener, and fructo. Additional ingredients may further be included, including oligosaccharides, maple syrup, vanilla paste, and edible flavorings.
L-카르니틴은 지방산 대사에 필수적인 작용을 하는 조효소로 아미노산 유도체이다. L-카르니틴은 의약품용으로 협심증이나 급성 심근경색과 같은 허혈성 심장질환 및 뇌질환 치료에 사용되고, 체지방 감소에 도움을 주는 건강 기능성 식품의 원료로도 사용된다. L-carnitine is an amino acid derivative and a coenzyme that plays an essential role in fatty acid metabolism. L-carnitine is used in medicine to treat ischemic heart disease and brain diseases such as angina pectoris and acute myocardial infarction, and is also used as an ingredient in health functional foods that help reduce body fat.
아몬드 프로틴 파우더는 아몬드에서 추출한 단백질로, 근육을 구성하는 섬유질이 줄어드는 근감소증에 도움을 준다. 아몬드 프로틴 파우더는, 순수 단백질 함량이 41 내지 46%인 것을 사용할 수 있다. Almond protein powder is a protein extracted from almonds that helps with sarcopenia, a condition in which the fibers that make up muscles decrease. Almond protein powder can be used with a pure protein content of 41 to 46%.
유청 단백질은 가수분해 유청 단백질(WPH, whey protein hydrolysates) 및 분리유청 단백질(WPI, whey protein isolate)의 혼합물일 수 있다. Whey protein may be a mixture of whey protein hydrolysates (WPH) and whey protein isolate (WPI).
상기 가수분해 유청 단백질은, 단백질 순도 98% 이상으로, 흡수율은 생물가 167 으로 15분 내 빠른 흡수가 이루어진다. WPI를 더 필터링해서 유당을 완전 제거하고 생물가를 최고로 높이고, 가장 높은 순도를 갖는 유청 단백질이다. WPH는 신체가 더 많은 질소를 보유하게 할 뿐만 아니라, 일반적인 형태의 아미노산 보다 훨씬 흡수가 빠른 트라이펩타이드(Tri-peptade)로 분해되어 혈류 속에 가장 빠르게 흡수된다. 따라서, 운동 직후 동화작용을 촉진하고 근육붕괴를 최대한 막아주며, 단백질 합성을 최고로 증가시켜주는 최고의 단백질로 꼽힌다.The hydrolyzed whey protein has a protein purity of over 98%, an absorption rate of 167, and rapid absorption within 15 minutes. WPI is further filtered to completely remove lactose, has the highest biological value, and is the whey protein with the highest purity. Not only does WPH help the body retain more nitrogen, but it is also broken down into tri-peptide, which is absorbed more quickly than the typical amino acid form, so it is most quickly absorbed into the bloodstream. Therefore, it is considered the best protein that promotes anabolism immediately after exercise, prevents muscle breakdown as much as possible, and maximizes protein synthesis.
상기 분리유청 단백질은 단백질 순도 70% 이상으로 흡수율은 생물가 159으로 30분 내 흡수가 이루어진다. WPC를 p번 더 필터링해서 유당까지 제거한 상태라서 단백질의 순도가 높다. The whey protein isolate has a protein purity of 70% or more, has a biological value of 159, and is absorbed within 30 minutes. WPC has been filtered p more times to remove lactose, so the purity of the protein is high.
카라기난은 아이리쉬 모스(lrish moss)라고 하는 홍조류 진도박(Chondrus)과 석초(Giartina)의 세포간 물질을 추출하여 얻은 점성 고분자 전해질인 다당류 혼합물로서 식품의 분산제, 안정제 등으로 광범위하게 사용되고 있다.Carrageenan is a viscous polyelectrolyte polysaccharide mixture obtained by extracting the intercellular material of the red algae Chondrus and Giartina, also known as Irish moss, and is widely used as a dispersant and stabilizer in foods.
타우린은 아미노산의 일종으로, 자양강장제, 피로회복제 등 드링크 제품의 주성분으로 잘 알려져 있다. 식물에는 거의 들어있지 않으나 동물에는 하등에서 고등동물까지 널리 분포되어 있으며, 특히 사람과 포유동물의 인체내에서는 주요 장기인 심장, 뇌, 간 등에 다량 함유되어 있다.Taurine is a type of amino acid and is well known as a main ingredient in drink products such as a tonic and fatigue reliever. Although it is rarely contained in plants, it is widely distributed in animals from lower to higher animals. In particular, it is contained in large amounts in major organs such as the heart, brain, and liver in the human body and mammals.
타우린은 뇌의 교감신경에 대해 억제작용을 나타내어 혈압의 안정화 및 뇌졸중의 예방에 도움이 된다. 또한, 심장의 저칼슘 상태에서 심근의 수축력이 저하할 때 수축력을 증가시키고, 고칼슘의 경우 수축력을 감소시켜 부정맥이나 심부전에 유효하다고 알려져 있다.Taurine has an inhibitory effect on the sympathetic nerves of the brain, helping to stabilize blood pressure and prevent stroke. In addition, it is known to be effective in treating arrhythmia or heart failure by increasing the contractility of the myocardium when the contractility of the myocardium decreases in a low-calcium state of the heart, and decreasing the contractility in the case of high calcium.
이 밖에 동맥경화·협심증·심근경색 등을 유발하는 저밀도 지단백질(LDL) 콜레스테롤의 생성을 억제하고, 혈관 조직에 침투되어 있는 콜레스테롤을 분해시키는 고밀도 비단백질(HDL) 콜레스테롤의 양을 증가시켜, 혈관 내 혈소판 응집작용 뿐만 아니라 각종 혈관계 질환의 예방에 효과가 있다고 알려져 있다.In addition, it suppresses the production of low-density lipoprotein (LDL) cholesterol, which causes arteriosclerosis, angina, and myocardial infarction, and increases the amount of high-density non-protein (HDL) cholesterol, which decomposes cholesterol infiltrated into vascular tissue. It is known to be effective in preventing platelet aggregation as well as various vascular diseases.
잔탄검은 식품의 점착성 및 점도를 증가시키고 유화 안정성을 증진하며 식품의 물성 및 촉감을 향상시키기 위한 식품 첨가물이다. 식품에서 안정제, 증점제, 결착제, 유화제, 고결제, 발포제 등으로 사용된다.Xanthan gum is a food additive that increases the adhesiveness and viscosity of food, improves emulsion stability, and improves the physical properties and texture of food. It is used in food as a stabilizer, thickener, binder, emulsifier, setting agent, and foaming agent.
천연 증점제인 잔탄검은 양배추의 엽소병 원인균인 잔토모나스 캄페스트리스(Xanthomonas Campestris) 균을 사용하여 탄수화물을 순수 배양 발효하여 얻은 고분자 다당류 검물질을 아이소프로필알코올에 정제, 건조, 분쇄한 것으로서, 포도당, 마노스 및 글루크론산의 나트륨, 칼륨 및 칼슘염 등으로 구성된 혼합물이다.Xanthan gum, a natural thickener, is a high-molecular polysaccharide gum obtained by pure culture fermentation of carbohydrates using Xanthomonas Campestris, the causative agent of leaf spot disease of cabbage, and purified, dried, and ground in isopropyl alcohol. It contains glucose, It is a mixture composed of sodium, potassium and calcium salts of mannose and glucuronic acid.
시서스는 그리스어로 담쟁이덩굴을 뜻하며 '포도아이비'라고 불리는 생명력이 강한 엔렌다니카와'캥거루이이비'라고 불리는 안타르티카 등 다양한 품종이 있다. 시서스 안타르티카는 잎이 난형으로 밝은 녹색이고 가장자리에 엉성한 톱니가 있다. 덩굴손이 있어서 다른 물체에 매달리는 특성이 있어 끈으로 연결시켜 유인하여 기를 수 있다.Cissus means ivy in Greek, and there are various varieties, including the vigorous Enrendanica, called 'grape ivy', and Antartica, called 'kangaroo ivy'. Cissus antarctica has ovate, bright green leaves with rough sawtooth edges. It has tendrils that allow it to hang on to other objects, so it can be grown by luring it by connecting it with a string.
시서스는, 안티 리파아제 성분이 풍부하여 지방 흡수를 감소시키고, 혈청 세로토닌 수치를 증가시켜 포만감을 높여준다. 또한, 뼈와 관절을 튼튼하게 하고, 통증과 염증 완화에 도움이 된다. Cissus is rich in anti-lipase ingredients, which reduces fat absorption and increases the feeling of fullness by increasing serum serotonin levels. It also strengthens bones and joints and helps relieve pain and inflammation.
시서스는 통상의 방법에 의해 분말 형태로 제조된 것을 사용할 수 있다. Cissus can be used in powder form by conventional methods.
프락토 올리고당은 극히 소량이 위산에 의해 가수분해되어 과당과 포도당으로 흡수되며, 거의 대부분은 소화효소에 의해 분해되지 않고 대장에서 장내 균에 의해 발효된다. 발효의 결과로 생성된 단쇄지방산은 장내 환경을 산성화하며, 장내 균이 사용할 수 있는 손쉬운 에너지원으로 작용한다. 따라서, 유해균은 감소되고 유익한 비피더스균 등이 현저히 증가되어 장내 균총이 변하게 된다.A very small amount of fructooligosaccharides is hydrolyzed by stomach acid and absorbed into fructose and glucose, and most of it is not broken down by digestive enzymes and is fermented by intestinal bacteria in the large intestine. Short-chain fatty acids produced as a result of fermentation acidify the intestinal environment and act as an easy energy source that intestinal bacteria can use. Therefore, harmful bacteria are reduced and beneficial bifidobacteria are significantly increased, thereby changing the intestinal flora.
프락토 올리고당은 비피더스균의 성장 촉진과 더불어 간접적으로 장의 연동운동을 촉진시킬 수 있다.In addition to promoting the growth of bifidobacteria, fructooligosaccharides can indirectly promote intestinal peristalsis.
설탕 대체 감미료는, 설탕과 유사한 단맛을 내나, 체내에 거의 흡수되지 않고 배출되므로 저칼로리 감미료일 수 있다. 예를 들어, 에리스리톨 또는 효소처리 스테비아일 수 있다. Sugar substitute sweeteners have a sweet taste similar to sugar, but are hardly absorbed into the body and are excreted, so they may be low-calorie sweeteners. For example, it may be erythritol or enzymatically treated stevia.
상기 식이섬유는, 다이어트와 변비에 효능이 있다고 알려진 영양소로써, 식물의 세포벽에 존재하여 식물의 형태를 유지시키며, 셀룰로오스, 팩틴, 리그닌 등의 종류가 있다.The dietary fiber is a nutrient known to be effective in dieting and constipation. It exists in the cell walls of plants to maintain the shape of the plant, and includes types such as cellulose, pectin, and lignin.
이러한 식이섬유는 섭취 시 사람의 소화 효소로는 소화시킬 수 없고, 위나 장에 통과하는 속도가 느려 포만감을 부여하고, 혈당 상승을 억제한다는 특징이 있다.These dietary fibers cannot be digested by human digestive enzymes when ingested, and have the characteristic of slowing down their passage through the stomach or intestines, providing a feeling of fullness and suppressing the rise in blood sugar levels.
상기 식이섬유는 식품에 포함되어 총 열량을 절감시켜 체중감량 효과를 비롯하여 각종 대사성 질환의 발병율을 감소시킬수 있으며, 장내 유산균 환경을 지원하여 면역력의 강화에도 도움을 줄 수 있다.The dietary fiber is included in food and can reduce the total calories, thereby reducing the incidence of various metabolic diseases, including weight loss effects. It can also help strengthen immunity by supporting the intestinal lactic acid bacteria environment.
상기 식이섬유는, 수용성 식이섬유, 일례로, 화이버솔을 사용할 수 있다. The dietary fiber may be water-soluble dietary fiber, for example, fiber sole.
바닐라는 풍부한 꽃향기와 달콤한 향, 계피를 떠올리게 하는 풍미를 가지고 있다. 크게 말린 바닐라 열매 자체인 바닐라 꼬투리, 꼬투리를 갈아서 만든 순수한 가루 결정체 혹은 여기에 설탕, 녹말가루 등을 첨가하여 만든 가루인 바닐라 파우더, 술의 주성분인 에탄올에 바닐라 꼬투리를 담가 만든 바닐라 엑스트랙트(extract), 바닐라 열매와 설탕을 섞어 만든 바닐라 슈거 등으로 사용된다.Vanilla has a rich floral and sweet scent, and a flavor reminiscent of cinnamon. Vanilla pods, which are the large dried vanilla pods themselves, pure powdered crystals made by grinding the pods, or vanilla powder, which is a powder made by adding sugar, starch powder, etc., and vanilla extract made by soaking vanilla pods in ethanol, the main ingredient in alcohol. , used as vanilla sugar made by mixing vanilla fruit and sugar.
한편, 바닐라에는 항산화 물질이 풍부하게 함유되어 있어 암 예방과 함께 신체의 세포와 조직이 파괴되는 것을 방지하는 효능이 있다. 또한, 면역체계를 보호하고 신체에 가해지는 스트레스를 줄이는 데도 도움을 준다.Meanwhile, vanilla is rich in antioxidants, which have the effect of preventing cancer and preventing the body's cells and tissues from being destroyed. It also helps protect the immune system and reduce stress on the body.
상기 바닐라는 바닐라 빈의 씨앗을 긁어 모아 페이스트 형태로 제조한 바닐라 페이스트를 사용할 수 있다. The vanilla can be used as a vanilla paste made by scraping the seeds of vanilla beans into a paste form.
상기 식용 향료는, 예를 들어, 버터향, 밀크향, 오렌지향, 호두향, 레몬향, 바나나향 등의 통상의 식용 향료를 사용할 수 있다. The edible flavoring agent may be, for example, a typical edible flavoring material such as butter flavor, milk flavor, orange flavor, walnut flavor, lemon flavor, or banana flavor.
상기 도넛은, 총 중량에 대하여, 상기 L-카르니틴 0.1 내지 1 중량%, 상기 아몬드 프로틴 파우더 2 내지 5 중량%, 상기 유청 단백질 3 내지 7 중량%, 상기 카라기난 0.1 내지 1 중량%, 상기 타우린 0.1 내지 1 중량%, 상기 잔탄검 0.1 내지 0.5 중량%, 상기 시서스 분말 0.1 내지 1 중량%, 상기 키토 올리고당 0.4 내지 1 중량%, 상기 식이섬유 0.1 내지 1 중량%, 상기 난백분 1 내지 1.5 중량%, 상기 대두레시틴 0.1 내지 0.6 중량%, 상기 베이킹 파우더 1 내지 3 중량%, 상기 탄산칼슘 0.1 내지 2 중량%, 상기 정제염 0.1 내지 1 중량%, 상기 설탕 대체 감미료 3 내지 6 중량%, 상기 프락토올리고당 1 내지 2 중량%, 상기 메이플 시럽 1 내지 2 중량%, 상기 바닐라 페이스트 0.1 내지 1 중량% 및 상기 식용 향료 0.01 내지 2 중량%로 추가 성분을 더 포함할 수 있다. The donut contains 0.1 to 1% by weight of the L-carnitine, 2 to 5% by weight of the almond protein powder, 3 to 7% by weight of the whey protein, 0.1 to 1% by weight of the carrageenan, and 0.1 to 1% by weight of the taurine, based on the total weight. 1% by weight, 0.1 to 0.5% by weight of the xanthan gum, 0.1 to 1% by weight of the Cissus powder, 0.4 to 1% by weight of the chito-oligosaccharides, 0.1 to 1% by weight of the dietary fiber, 1 to 1.5% by weight of the egg white powder, 0.1 to 0.6% by weight of soy lecithin, 1 to 3% by weight of the baking powder, 0.1 to 2% by weight of the calcium carbonate, 0.1 to 1% by weight of the refined salt, 3 to 6% by weight of the sugar substitute sweetener, 1 to 1% by weight of the fructooligosaccharide Additional ingredients may be further included, such as 2% by weight, 1 to 2% by weight of the maple syrup, 0.1 to 1% by weight of the vanilla paste, and 0.01 to 2% by weight of the edible flavoring.
도 1 내지 도 4는, 본 발명의 일 실시예에 따른 체중 조절용 도넛을 제조하는 단계를 수행하는 실제 사진이다.1 to 4 are actual photos of the steps of manufacturing a donut for weight control according to an embodiment of the present invention.
도 1을 참조하면, 분말 성분과 액상 성분을 혼합하여 반죽물을 제조할 수 있다. Referring to Figure 1, dough can be prepared by mixing powder ingredients and liquid ingredients.
상기 분말 성분은, 가르시니아 캄보지아 추출분말, 그린커피빈 추출분말, L-카르니틴, 아몬드 프로틴 파우더, 유청 단백질 분말, 카라기난, 타우린, 잔탄검, 시서스 분말, 식이섬유, 견과류 분말, 난백분, 대두레시틴, 베이킹 파우더, 탄산칼슘, 정제염 및 설탕 대체 감미료를 포함할 수 있다. The powder ingredients include garcinia cambogia extract powder, green coffee bean extract powder, L-carnitine, almond protein powder, whey protein powder, carrageenan, taurine, xanthan gum, cissus powder, dietary fiber, nut powder, egg white powder, soy lecithin, May contain baking powder, calcium carbonate, refined salt, and sugar substitute sweeteners.
상기 분말 성분은, 각각 전술된 함량에 따라 각각 계량한 다음, 혼합 및 교반한 다음, 100 mesh 이상의 체에 2회 정도 여과시킬 수 있다. 이로써, 고운 입자 크기를 갖는 분말 혼합물을 제조할 수 있다. The powder components can be individually weighed according to the above-mentioned content, mixed and stirred, and then filtered twice through a sieve of 100 mesh or more. Thereby, a powder mixture having a fine particle size can be produced.
상기 액상 성분은, 키토올리고당, 프락토 올리고당, 메이플 시럽, 바닐라 페이스트, 식용 향료 및 코코넛 밀크를 포함할 수 있다. 상기 액상 성분은, 각각 전술된 함량에 따라 혼합하여 액상 혼합물을 제조할 수 있다. The liquid ingredient may include chitooligosaccharide, fructooligosaccharide, maple syrup, vanilla paste, edible flavoring, and coconut milk. The liquid ingredients can be mixed according to the above-mentioned amounts to prepare a liquid mixture.
상기 분말 혼합물과 액상 혼합물을 혼합하여 교반할 수 있다. 상기 교반은 주걱과 같은 통상의 도구를 사용하여 분말의 가루가 보이지 않을 때까지 저어주는 것일 수 있다. 상기 반죽물은 짤주머니를 통해 일정 직경을 갖는 긴 원통형의 형태로 나올 수 있는 정도로 적절한 점도를 나타내도록 제조될 수 있다. The powder mixture and the liquid mixture can be mixed and stirred. The stirring may be performed using a common tool such as a spatula until the powder is no longer visible. The dough can be manufactured to have an appropriate viscosity to the extent that it can come out in the form of a long cylindrical shape with a certain diameter through a piping bag.
도 2를 참조하면, 상기 반죽물을 짤주머니를 사용하여 도넛 제조용 팬에 도포하고, 팬닝(panning)하는 단계를 수행할 수 있다. Referring to Figure 2, the step of applying the dough to a donut manufacturing pan using a piping bag and panning can be performed.
상기 도넛 제조용 팬의 형상은, 일반적인 도넛 모양인 고리 모양, 사바랭 모양. 원형, 사각, 하트 등 다양한 모양을 가질 수 있으며, 특별히 한정되지는 않는다. The shape of the pan for making donuts is a ring shape, which is a general donut shape, and a Savarin shape. It can have various shapes such as round, square, and heart, but is not particularly limited.
상기 팬닝을 수행할 때에는, 반죽물이 고루 펴지도록 요리용 붓 등의 도구를 사용하여 표면을 정리할 수 있다. When performing the panning, the surface can be prepared using a tool such as a cooking brush so that the dough is spread evenly.
도 3을 참조하면, 팬닝 후에 컨백션 오븐에서 예를 들어, 164~166℃ 에서, 14 내지 16분간 구워서 도넛을 제조할 수 있다. Referring to Figure 3, after panning, donuts can be manufactured by baking them in a convection oven at, for example, 164 to 166°C for 14 to 16 minutes.
본 발명에서는, 오븐에 굽는 방식으로 도넛을 제조함으로써, 보다 부드러운 식감과 담백한 맛을 제공할 수 있도록 한다. In the present invention, donuts are manufactured by baking them in an oven, thereby providing a softer texture and a lighter taste.
또한, 컨백션 오븐을 사용하여 도넛을 제조할 경우, 표면은 쿠키나 비스킷 같은 식감을 나타내고 내부는 부드럽고 촉촉한 상태를 유지할 수 있도록 하여 도넛의 식감에 대한 관능성을 높일 수 있다.In addition, when manufacturing donuts using a convection oven, the surface exhibits a cookie or biscuit-like texture and the interior remains soft and moist, thereby increasing the sensory sensitivity of the texture of the donut.
완성된 도넛은 상온, 19 내지 25℃ 에서 냉각한 후, 포장을 수행할 수 있다. The finished donuts can be cooled to room temperature, 19 to 25°C, and then packaged.
도 5는, 본 발명의 일 실시예에 따라 제조된 체중 조절용 도넛의 사진이다.Figure 5 is a photograph of a donut for weight control manufactured according to an embodiment of the present invention.
도 5를 참조하면, 컨백션 오븐을 사용하여 구워내어, 겉은 쿠키와 같은 바삭한 식감을 나타내고 내부는 빵처럼 부드럽고 촉촉한 식감을 나타낼 수 있는 체중 조절용 도넛을 제조하였다. Referring to Figure 5, a donut for weight control was manufactured that was baked using a convection oven to have a crispy texture like a cookie on the outside and a soft and moist texture like bread on the inside.
이하, 구체적인 실시예와 비교예를 통하여 본 발명의 구성 및 그에 따른 효과를 보다 상세히 설명하고자 한다. 그러나, 본 실시예는 본 발명을 보다 구체적으로 설명하기 위한 것이며, 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다.Hereinafter, the configuration of the present invention and its effects will be described in more detail through specific examples and comparative examples. However, these examples are for illustrating the present invention in more detail, and the scope of the present invention is not limited to these examples.
[실시예 1 내지 실시예 3][Example 1 to Example 3]
분말 성분과 액상 성분을 모두 혼합하여 반죽한 반죽물을 짤주머니에 넣어 도넛 제조용 팬에 도포하고, 팬닝을 수행하였다. 팬닝 후에 컨백션 오븐에서 165℃ 에서 15분간 구워서 도넛을 각각 제조하였다. 실시예 1 내지 실시예 3의 반죽물 내 구성 성분과 함량에 대하여는 하기 표 1에 나타내었다. The dough made by mixing both the powder and liquid ingredients was placed in a piping bag and applied to a pan for making donuts, and panning was performed. After panning, donuts were prepared by baking them in a convection oven at 165°C for 15 minutes. The components and contents of the dough of Examples 1 to 3 are shown in Table 1 below.
[비교예 1 내지 비교예 3][Comparative Examples 1 to 3]
실시예 1의 제조방법에 따라 도넛을 제조하되, 반죽물 내 구성성분 및 함량을 달리하였다. 비교예 1 내지 비교예 3의 반죽물 내 구성 성분과 함량에 대하여는 하기 표 1에 나타내었다.Donuts were manufactured according to the manufacturing method of Example 1, but the components and contents of the dough were varied. The components and contents of the dough of Comparative Examples 1 to 3 are shown in Table 1 below.
[비교예 4][Comparative Example 4]
후술되는 내용을 제외하고는, 상기 실시예 1의 반죽물의 성분 및 함량을 동일하게 하여 도넛을 제조하였다(성분 및 함량이 표 1의 실시예 1과 동일함).Except as described below, donuts were manufactured using the same ingredients and contents of the dough as in Example 1 (the ingredients and contents were the same as Example 1 in Table 1).
컨백션 오븐에서 170℃에서 15분간 구워서 도넛을 제조하였다. Donuts were prepared by baking them in a convection oven at 170°C for 15 minutes.
[비교예 5][Comparative Example 5]
후술되는 내용을 제외하고는, 상기 실시예 1의 반죽물의 성분 및 함량을 동일하게 하여 도넛을 제조하였다(성분 및 함량이 표 1의 실시예 1과 동일함).Except as described below, donuts were manufactured using the same ingredients and contents of the dough as in Example 1 (the ingredients and contents were the same as Example 1 in Table 1).
컨백션 오븐을 사용하지 않고, 통상의 공지된 도넛 제조방법에 따라 기름에 튀기는 방법으로 도넛을 제조하였다. Donuts were manufactured by frying in oil according to a commonly known donut manufacturing method without using a convection oven.
<실험예 : 관능테스트 평가><Experimental example: Sensory test evaluation>
실시예 1 내지 실시예 3, 및 비교예 1 내지 비교예 5에 의해 제조된 각 도넛에 대하여, 길거리의 무작위 손님 30 인(성별, 나이 무관)에게 무상으로 제공하여 관능테스트를 실시하였다(1점: 매우 불량, 2점: 불량, 3점: 보통, 4점: 양호, 5점: 매우 양호). 상기 관능테스트는 3점 보통을 기준으로 하여 맛, 향, 기호도에 대해 5점 척도법으로 평가하였고, 그 결과를 하기 표 2에 나타내었다.Each donut manufactured in Examples 1 to 3 and Comparative Examples 1 to 5 was provided free of charge to 30 random street customers (regardless of gender and age) and a sensory test was conducted (1 point). : very poor, 2 points: poor, 3 points: average, 4 points: good, 5 points: very good). The sensory test was evaluated on a 5-point scale for taste, aroma, and preference, with 3 points being normal, and the results are shown in Table 2 below.
상기 표 2에 나타낸 바와 같이, 본 발명에 따른 조건으로 제조되는 체중 조절용 도넛의 경우 맛, 향, 식감 및 기호도 모든 부분에서 상당히 우수한 평가를 받았으며, 특히 실시예 2의 도넛의 경우 가장 높은 점수를 나타내었다.As shown in Table 2, the donuts for weight control manufactured under the conditions according to the present invention were evaluated as excellent in all aspects including taste, aroma, texture, and preference. In particular, the donut of Example 2 received the highest score. It was.
본 명세서에서는 본 발명자들이 수행한 다양한 실시예 가운데 몇 개의 예만을 들어 설명하는 것이나 본 발명의 기술적 사상은 이에 한정하거나 제한되지 않고, 당업자에 의해 변형되어 다양하게 실시될 수 있음은 물론이다.In this specification, only a few examples of various embodiments performed by the present inventors are described, but the technical idea of the present invention is not limited or limited thereto, and of course, it can be modified and implemented in various ways by those skilled in the art.
Claims (3)
상기 분말 혼합물에 코코넛 밀크, 우유, 계란 및 코코넛 오일을 포함하는 액상 성분을 혼합하여 반죽물을 형성하는 단계;
상기 반죽물을 짤주머니를 사용하여 도넛 제조용 팬에 도포하고, 팬닝(panning)하는 단계; 및
팬닝 후에 컨백션 오븐에서 164 내지 166℃ 에서, 14 내지 16분간 구워서 도넛을 제조하는 단계; 를 포함하고,
상기 분말 성분은, 도넛 총 중량에 대하여, 상기 가르시니아 캄보지아 추출분말 2 내지 3.5 중량%, 상기 그린커피빈 추출분말 0.1 내지 1 중량% 및 상기 견과류 분말 28 내지 35 중량%로 포함하고,
L-카르니틴 0.1 내지 1 중량%, 아몬드 프로틴 파우더 2 내지 5 중량%, 유청 단백질 3 내지 7 중량%, 카라기난 0.1 내지 1 중량%, 타우린 0.1 내지 1 중량%, 잔탄검 0.1 내지 0.5 중량%, 시서스 분말 0.1 내지 1 중량%, 식이섬유 0.1 내지 1 중량%, 난백분 1 내지 1.5 중량%, 대두레시틴 0.1 내지 0.6 중량%, 베이킹 파우더 1 내지 3 중량%, 탄산칼슘 0.1 내지 2 중량%, 정제염 0.1 내지 1 중량% 및 설탕 대체 감미료 3 내지 6 중량%을 더 포함하고,
상기 액상 성분은, 도넛 총 중량에 대하여, 상기 코코넛 밀크 5 내지 8 중량%, 상기 우유 8 내지 13 중량%, 상기 계란 5 내지 8 중량% 및 상기 코코넛 오일 10 내지 14 중량%로 포함하고,
키토 올리고당 0.4 내지 1 중량%, 프락토올리고당 1 내지 2 중량%, 메이플 시럽 1 내지 2 중량%, 바닐라 페이스트 0.1 내지 1 중량% 및 식용 향료 0.01 내지 2 중량%을 더 포함하는 것을 특징으로 하는, 체중 조절용 도넛 제조방법.Mixing powder ingredients including garcinia cambogia extract powder, green coffee bean extract powder, and nut powder and filtering them twice through a sieve to prepare a powder mixture having a size of 100 mesh or more;
Forming a dough by mixing liquid ingredients including coconut milk, milk, eggs, and coconut oil with the powder mixture;
Applying the dough to a pan for making donuts using a piping bag and panning; and
Manufacturing donuts by baking them in a convection oven at 164 to 166°C for 14 to 16 minutes after panning; Including,
The powder ingredients include 2 to 3.5% by weight of the garcinia cambogia extract powder, 0.1 to 1% by weight of the green coffee bean extract powder, and 28 to 35% by weight of the nut powder, based on the total weight of the donut,
L-carnitine 0.1 to 1% by weight, almond protein powder 2 to 5% by weight, whey protein 3 to 7% by weight, carrageenan 0.1 to 1% by weight, taurine 0.1 to 1% by weight, xanthan gum 0.1 to 0.5% by weight, cissus Powder 0.1 to 1% by weight, dietary fiber 0.1 to 1% by weight, egg white powder 1 to 1.5% by weight, soy lecithin 0.1 to 0.6% by weight, baking powder 1 to 3% by weight, calcium carbonate 0.1 to 2% by weight, refined salt 0.1 to 1%. % by weight and further comprising 3 to 6 wt% of a sugar substitute sweetener,
The liquid ingredient includes 5 to 8% by weight of the coconut milk, 8 to 13% by weight of the milk, 5 to 8% by weight of the egg, and 10 to 14% by weight of the coconut oil, based on the total weight of the donut,
Characterized in that it further comprises 0.4 to 1% by weight of chitooligosaccharides, 1 to 2% by weight of fructooligosaccharides, 1 to 2% by weight of maple syrup, 0.1 to 1% by weight of vanilla paste, and 0.01 to 2% by weight of edible flavoring. How to make adjustable donuts.
Publications (1)
Publication Number | Publication Date |
---|---|
KR102680172B1 true KR102680172B1 (en) | 2024-07-01 |
Family
ID=
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050003026A1 (en) | 2002-08-14 | 2005-01-06 | Song-Hae Bok | Powder or extracts of plant leaves with anti-obesity effects and anti-obesity food comprising them |
KR100488409B1 (en) | 2002-10-23 | 2005-05-10 | (주)바이오뉴트리젠 | A coffee composition comprising polyphenols, bioflavonoids or extracts of plants comprising polyphenols or bioflavonoids for improving the metabolism of the lipid and suppressing the fatness |
KR101813545B1 (en) | 2016-07-22 | 2017-12-29 | 이혜란 | Doughnut type seolki preparing method |
KR102330501B1 (en) * | 2020-07-28 | 2021-12-29 | 김범안 | Baked doughnut and manufacturing method thereof |
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050003026A1 (en) | 2002-08-14 | 2005-01-06 | Song-Hae Bok | Powder or extracts of plant leaves with anti-obesity effects and anti-obesity food comprising them |
KR100488409B1 (en) | 2002-10-23 | 2005-05-10 | (주)바이오뉴트리젠 | A coffee composition comprising polyphenols, bioflavonoids or extracts of plants comprising polyphenols or bioflavonoids for improving the metabolism of the lipid and suppressing the fatness |
KR101813545B1 (en) | 2016-07-22 | 2017-12-29 | 이혜란 | Doughnut type seolki preparing method |
KR102330501B1 (en) * | 2020-07-28 | 2021-12-29 | 김범안 | Baked doughnut and manufacturing method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4857326A (en) | Stable nutritive and therapeutic flax seed compositions, methods of preparing the same, and therapeutic methods employing the same | |
JP2000505308A (en) | Compositions and their use as food supplements or for lowering serum lipids | |
KR100921999B1 (en) | Spicy Ice Cream Using Natural Ingredients and Its Manufacturing Method | |
JP2000166467A (en) | Health food containing fermented milk product and herbs | |
KR101731168B1 (en) | METHOD OF MANUFACTURING PILL COMPRISED OF Protaetia brevitarsis seulensis | |
KR102680172B1 (en) | Donut containing ingredient that help with weight control | |
KR100955043B1 (en) | Powder composition of cake for weight loss and manufacturing method of cake using the same | |
KR100816079B1 (en) | Method for preparation of functional rice and the prepared rice | |
KR101905514B1 (en) | Manufacturing method of rice korokke and korokke using the same | |
RU2739423C1 (en) | Fishy semi-finished quenelles products | |
KR101583186B1 (en) | Yanggaeng comprising fermented composition of cheonggukjang and manufacturing method thereof | |
JP3935490B2 (en) | Soymilk kefir and method for producing the same | |
CN109452627A (en) | A kind of preparation method of Semen sesami nigrum walnut honeyed bolus | |
CN107455712A (en) | The additive-free All-in-One nut based food of oil-free | |
JP2007117094A (en) | Health food containing milk fermented product and herb | |
KR20110080687A (en) | Composite yacon & fucoidan seaweed salt with a component including black garlic green tea bag | |
PL242612B1 (en) | Vegetable paste and method of making vegetable paste | |
RU2739804C1 (en) | Composition of fish semi-finished products for child nutrition | |
RU2579215C1 (en) | Dry mixture for beverage preparation | |
CN109699715A (en) | A kind of cherry rose mulberry stuffings and preparation method thereof | |
RU2779745C2 (en) | Functional ice cream (options) and its production method | |
CN113424934B (en) | Purple sweet potato sausage and preparation method thereof | |
CN104222300A (en) | Uncongealed beancurd with entermorpha prolifera | |
RU2713687C1 (en) | Gluten-free cake composition | |
RU2649182C1 (en) | Application of flour of plantago psyllium l. sunships seeds in cooked sausage products |